Pharma launches are high-risk and high-cost. Many promising drugs fail to meet commercial expectations. Recent industry analysis shows about 58% of drug launches miss expectations.Read More
AI is transforming the pharmaceutical industry in 2025—driving breakthroughs in drug discovery, optimizing manufacturing, and fixing broken supply chains.Read More
2025 is turning out to be one of the most pivotal years for pharmaceutical M&A activity in recent history.Read More
In June 2025, the government imposed anti-dumping duties on four chemicals—most of them sourced from China.Read More
The global cosmetic industry valued at $450 billion in 2025 isn’t just expanding.Read More